İlhan Işıkdağ

812 total citations
21 papers, 703 citations indexed

About

İlhan Işıkdağ is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, İlhan Işıkdağ has authored 21 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Toxicology. Recurrent topics in İlhan Işıkdağ's work include Synthesis and biological activity (12 papers), Synthesis and Biological Evaluation (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). İlhan Işıkdağ is often cited by papers focused on Synthesis and biological activity (12 papers), Synthesis and Biological Evaluation (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). İlhan Işıkdağ collaborates with scholars based in Türkiye. İlhan Işıkdağ's co-authors include Yusuf Özkay, Hülya Karaca, Yağmur Tunalı, Nalan Gündoğdu-Karaburun, Zerrin İncesu, Gülşen Akalın, Hülya Zeyti̇noǧlu, Berrin Ayaz Tüylü, Begüm Nurpelin Sağlık and Ulviye Acar Çevik and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Medicinal Chemistry and Archives of Pharmacal Research.

In The Last Decade

İlhan Işıkdağ

20 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İlhan Işıkdağ Türkiye 8 610 139 65 47 39 21 703
Anelia Ts. Mavrova Bulgaria 16 776 1.3× 215 1.5× 80 1.2× 80 1.7× 45 1.2× 36 937
Monika Gaba India 9 719 1.2× 182 1.3× 103 1.6× 69 1.5× 64 1.6× 13 903
Chander Mohan India 9 687 1.1× 192 1.4× 71 1.1× 59 1.3× 56 1.4× 28 829
B. Sooryanarayana Rao India 10 895 1.5× 128 0.9× 24 0.4× 61 1.3× 41 1.1× 15 961
Ramya V. Shingalapur India 7 527 0.9× 139 1.0× 48 0.7× 38 0.8× 57 1.5× 8 601
Pierre Chevallet France 11 535 0.9× 148 1.1× 30 0.5× 61 1.3× 41 1.1× 32 640
Anatholy Dimoglo Türkiye 8 726 1.2× 183 1.3× 77 1.2× 98 2.1× 54 1.4× 12 841
Nabila A. Kheder Egypt 20 1.2k 2.0× 154 1.1× 111 1.7× 52 1.1× 43 1.1× 78 1.3k
Zabiulla Zabiulla India 13 391 0.6× 83 0.6× 43 0.7× 61 1.3× 62 1.6× 30 478
Nitin Kumar India 13 497 0.8× 143 1.0× 52 0.8× 31 0.7× 60 1.5× 35 645

Countries citing papers authored by İlhan Işıkdağ

Since Specialization
Citations

This map shows the geographic impact of İlhan Işıkdağ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İlhan Işıkdağ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İlhan Işıkdağ more than expected).

Fields of papers citing papers by İlhan Işıkdağ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İlhan Işıkdağ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İlhan Işıkdağ. The network helps show where İlhan Işıkdağ may publish in the future.

Co-authorship network of co-authors of İlhan Işıkdağ

This figure shows the co-authorship network connecting the top 25 collaborators of İlhan Işıkdağ. A scholar is included among the top collaborators of İlhan Işıkdağ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İlhan Işıkdağ. İlhan Işıkdağ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sağlık, Begüm Nurpelin, et al.. (2019). Novel imidazole derivatives as antifungal agents: Synthesis, biological evaluation, ADME prediction and molecular docking studies. Phosphorus, sulfur, and silicon and the related elements. 194(9). 887–894. 17 indexed citations
2.
Özkay, Yusuf, et al.. (2012). Antimicrobial and anticancer effects of some 2-(substitutedsulfanyl)-N-(5-methyl-isoxazol-3-yl)acetamide derivatives. Medicinal Chemistry Research. 22(1). 211–218. 9 indexed citations
3.
Kutlu, Hatice Mehtap, et al.. (2011). AN INVESTIGATION OF MUTAGENIC ACTIVITIES OF SOME 9- SUBSTITUEDPHENANTHRENE DERIVATIVES WITH AMES / SALMONELLA / MICROSOME TEST. SHILAP Revista de lepidopterología. 4 indexed citations
4.
Özkay, Yusuf, Yağmur Tunalı, Hülya Karaca, & İlhan Işıkdağ. (2011). Antimicrobial Activity of a New Combination System of Benzimidazole and Various Azoles. Archiv der Pharmazie. 344(4). 264–271. 24 indexed citations
5.
Işıkdağ, İlhan, Yusuf Özkay, Zerrin İncesu, & Gülşen Akalın. (2011). Anticancer Activity of Some Bisbenzimidazoles. Zeitschrift für Naturforschung C. 66(9-10). 465–470. 2 indexed citations
6.
Özkay, Yusuf, Yağmur Tunalı, Hülya Karaca, & İlhan Işıkdağ. (2011). Antimicrobial activity of a new series of benzimidazole derivatives. Archives of Pharmacal Research. 34(9). 1427–1435. 47 indexed citations
7.
Kutlu, Hatice Mehtap, et al.. (2011). BAZI 9-SÜBSTİTÜE FENANTREN TÜREVLERİNİN MUTAJENİK AKTİVİTELERİNİN AMES / SALMONELLA / MİKROZOM TESTİ İLE ARAŞTIRILMASI.
8.
Işıkdağ, İlhan, Yusuf Özkay, & Zerrin İncesu. (2011). Synthesis and anticancer activity of some bisquinoxaline derivatives. 4 indexed citations
9.
Özkay, Yusuf, Yağmur Tunalı, Hülya Karaca, & İlhan Işıkdağ. (2010). Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moiety. European Journal of Medicinal Chemistry. 45(8). 3293–3298. 214 indexed citations
10.
Özkay, Yusuf, İlhan Işıkdağ, Zerrin İncesu, & Gülşen Akalın. (2010). Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl]acetamide derivatives and evaluation of their anticancer activity. European Journal of Medicinal Chemistry. 45(8). 3320–3328. 127 indexed citations
11.
Işıkdağ, İlhan, et al.. (2010). Mutagenicity of Bisbenzimidazole Derivatives. Zeitschrift für Naturforschung C. 65(1-2). 10–14. 3 indexed citations
12.
Işıkdağ, İlhan, et al.. (2008). Cytotoxic Effects of Some Perimidine Derivatives on F2408 and 5Rp7 Cell Lines. 2 indexed citations
13.
Özkay, Yusuf, et al.. (2007). Antiproliferative effects of some N‐benzylideneanilines. Cell Biochemistry and Function. 26(1). 102–106. 6 indexed citations
15.
Benkli, Kadriye, et al.. (2004). SYNTHESIS AND ANTITUMOR ACTIVITY OF SOME 6-CHLORO- AND 6,7-DICHLORO-2,3-DISUBSTITUTED- QUINOXALINE DERIVATIVES. 1 indexed citations
16.
İncesu, Zerrin, et al.. (2002). Synthesis and effects on intracellular calcium of some 1,3-bis-(heteroaryl substituted)benzene derivatives. Il Farmaco. 57(7). 543–548. 6 indexed citations
17.
Gündoğdu-Karaburun, Nalan, et al.. (2001). Synthesis and analgesic activity of some 1-benzyl-2-substituted-4,5-diphenyl-1H-imidazole derivatives. Il Farmaco. 56(4). 285–290. 217 indexed citations
18.
Işıkdağ, İlhan, et al.. (1999). Synthesis and analgesic activities of 2-substituted-1H-phenantro [9,10-d] imidazoles.. PubMed. 138(9). 453–6. 1 indexed citations
19.
Işıkdağ, İlhan, et al.. (1995). Studies on the determination of the physicochemical parameters of some commercially available sulfonamide drugs in Turkey. 1 indexed citations
20.
Işıkdağ, İlhan, et al.. (1989). Studies of the synthesis of some 4,5-di and 2,4,5-trisubstituted imidazole derivatives. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026